CASABONNE, D., O. REINA, Yolanda BENAVENTE, Nikolaus BECKER, Marc MAYNADIE, Lenka FORETOVÁ, Pierluigi COCCO, Anna GONZALEZ-NEIRA, Alexandra NIETERS, Paolo BOFFETTA, Jaap M. MIDDELDORP and Silvia DE SANJOSE. Single nucleotide polymorphisms of matrix metalloproteinase 9 (MMP9) and tumor protein 73 (TP73) interact with Epstein-Barr virus in chronic lymphocytic leukemia: results from the European case-control study EpiLymph. Haematologica. Italy: Ferrata Storti Foundation, 2011, vol. 96, No 2, p. 323-327. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2010.031161.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Single nucleotide polymorphisms of matrix metalloproteinase 9 (MMP9) and tumor protein 73 (TP73) interact with Epstein-Barr virus in chronic lymphocytic leukemia: results from the European case-control study EpiLymph
Authors CASABONNE, D. (724 Spain, guarantor), O. REINA (724 Spain), Yolanda BENAVENTE (276 Germany), Nikolaus BECKER (276 Germany), Marc MAYNADIE (250 France), Lenka FORETOVÁ (203 Czech Republic, belonging to the institution), Pierluigi COCCO (380 Italy), Anna GONZALEZ-NEIRA (724 Spain), Alexandra NIETERS (528 Netherlands), Paolo BOFFETTA (840 United States of America), Jaap M. MIDDELDORP (528 Netherlands) and Silvia DE SANJOSE (528 Netherlands).
Edition Haematologica, Italy, Ferrata Storti Foundation, 2011, 0390-6078.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Italy
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 6.424
RIV identification code RIV/00216224:14110/11:00055288
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3324/haematol.2010.031161
UT WoS 000287766500023
Keywords in English chronic lymphocytic leukemia; epidemiology; Epstein Barr virus; interaction; polymorphism
Tags International impact
Changed by Changed by: Mgr. Michal Petr, učo 65024. Changed: 2/2/2012 08:52.
Abstract
Using EpiLymph case-control data, we found that chronic lymphocytic leukemia patients were more likely to have abnormal reactive serological patterns to Epstein Barr virus than controls. Here, we aimed to assess whether this association is modified by genetic variants. We examined 1,305 Single Nucleotide Polymorphisms from 300 selected genes related to various pathways in 240 cases and 513 controls from five European centers. In a recessive model, patients positive to aberrant antibody pattern and homozygous for rare genotypes in rs8113877T > G or rs17576A > G of the MMP9 gene were at highest risk of chronic lymphocytic leukemia. In a dominant model, TP73 showed the highest risk in patients positive to aberrant antibody pattern and homozygous for the wild-type genotype in rs1885859G > C or rs3765701A > T. All interactions were additive and no main effect was observed. The strong interactions observed may be indicative of a specific pathway in cancer genesis. Confirmation of these results is warranted.
PrintDisplayed: 25/5/2024 20:11